Betrixaban-d6

• CAT Number: S000117
• CAS Number: 2098655-51-5
• Molecular Formula: C23H16D6ClN5O3
• Molecular Weight: 457.94
• Purity: ≥95%
• Target: Factor Xa
• IUPAC Name: 2-[[4-[(E)-[bis(trideuteriomethyl)hydrazinylidene]methyl]benzoyl]amino]-N-(5-chloropyridin-2-yl)-5-methoxybenzamide
• InChI: InChI=1S/C23H22ClN5O3/c1-29(2)26-13-15-4-6-16(7-5-15)22(30)27-20-10-9-18(32-3)12-19(20)23(31)28-21-11-8-17(24)14-25-21/h4-14H,1-3H3,(H,27,30)(H,25,28,31)/b26-13+/i1D3,2D3
• InChIKey: PGOYJYHMBCZDLN-YJKHHXLJSA-N
• SMILES: [2H]C([2H])([2H])N(C([2H])([2H])[2H])/N=C/C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl

Betrixaban-d6 (CAS: 2098655-51-5), a high-quality pharmaceutical research compound designed for advanced studies in anticoagulant and cardiovascular research. As a deuterated analog of Betrixaban, it offers enhanced stability and improved pharmacokinetic properties. Betrixaban-d6 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for thromboembolic disorders. Trusted by leading laboratories, Betrixaban-d6 is your go-to solution for cutting-edge anticoagulant research. Unlock new possibilities in blood clot prevention and treatment with Betrixaban-d6, where innovation meets reliability.